UPDATE: Sterne Agee Upgrades athenahealth on Core Revenue Growth Acceleration
UPDATE: Sterne Agee Initiates Coverage on AmerisourceBergen on Dominant Market Share
UPDATE: Sterne Agee Initiates Coverage on Cardinal Health on Dominant Market Share
UPDATE: Sterne Agee Initiates Coverage on McKesson on Market Leader Position
Greg T. Bolan Recent News
UPDATE: Sterne Agee Downgrades PAREXEL Following FY13 Results, FY14 Guidance
UPDATE: Sterne Agee Upgrades Quality Systems on Meaningful Improvement Forecast
UPDATE: Sterne Agee Raises PT on Quality Systems Following 8k Filing
Sterne Agee Reiterates Buy Rating on MedAssets Following Tenet/Vanguard Announcement
UPDATE: Sterne Agee Resumes athenahealth at Neutral on Valuation
UPDATE: Sterne Agee Initiates Cerner at Neutral on Valuation
UPDATE: Sterne Agee Initiates Quintiles Transnational Holdings at Underperform on Multiple Risk Factors
UPDATE: Sterne Agee Resumes MedAssets at Buy on Improving Profitability
UPDATE: Sterne Agee Resumes Charles River Laboratories at Buy on Multiple Positive Factors
UPDATE: Sterne Agee Resumes ICON at Neutral on Valuation
UPDATE: Sterne Agee Resumes Quality Systems at Neutral on Lowered Estimates
UPDATE: Sterne Agee Resumes PAREXEL at Neutral Following Raised Estimates
UPDATE: Sterne Agee Resumes Greenway Medical Technologies at Underperform on Share Overvalue
UPDATE: Sterne Agee Resumes Coverage on Albany Molecular Research at Buy on Good Market Position
UDPATE: Sterne Agee Resumes Allscripts Healthcare with Buy Rating, $17 PT on Continued Long-Term Turnaround
UPDATE: Sterne Agee Resumes Coverage on Covance with Neutral Rating, $76 PT on Current Valuation